Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

clopidrogel bisulfate

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Clopidogrel Bisulfate Manufacturers in India Suppliers Clopidogrel Bisulfate Exporters Distributors Clopidogrel Bisulfate api active pharmaceuticals ingredients Clopidogrel Bisulfate manufacturers Side Effects bulk drugs raw material Clopidogrel Bisulfate companies Side Effects Importers Clopidogrel Bisulfate Clopidogrel Bisulfate Exporters Clopidogrel Bisulfate exporters FDA Clopidogrel Bisulfate DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Clopidogrel Bisulfate manufacturing pharmaceutical drugs pharmaceutical intermediates Clopidogrel Bisulfate pharmaceutical chemicals pharmaceutical raw materials Clopidogrel Bisulfate active pharmaceutical ingredients Clopidogrel Bisulfate committee active pharmaceutical ingredients manufacturer Clopidogrel Bisulfate Active Pharmaceutical Ingredients manufacturer Clopidogrel Bisulfate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Clopidogrel Bisulfate, Clopidogrel Bisulfate manufacturer India, Clopidogrel Bisulfate product, Clopidogrel Bisulfate products, Api preparation, Certificate of Analysis API manufacturer product, Clopidogrel Bisulfate anti ulcer product, Certificate of Origin COA Clopidogrel Bisulfate COS Clopidogrel Bisulfate, pharmaceutical generic, pharmaceutical drug, medical, Clopidogrel Bisulfate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Clopidogrel Bisulfate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Clopidogrel Bisulfate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Clopidogrel Bisulfate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Clopidogrel Bisulfate ingredients, api, HIV Clopidogrel Bisulfate, tablets, capsules, syrup & protein Clopidogrel Bisulfate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Clopidogrel Bisulfate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Clopidogrel Bisulfate WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

clopidrogel bisulfate






 









 


 







 

 

HOME >> API >> API List1 >> Clopidogrel Bisulfate >> Pharmalogy

clopidrogel bisulfate


PHARMALOGY
Clopidogrel Bisulfate CAS number 135046-48-9

Clopidogrel is a pro-drug whose action may be related to adenosine diphosphate (ADP) receptor on platelet cell membranes. The specific subtype of ADP receptor that clopidogrel binds is P2Y12 and is important in platelet aggregation and the cross-linking of platelets by fibrin

The blockade of this receptor inhibits platelet aggregation by blocking activation of the glycoprotein IIb/IIIa pathway. The IIb/IIIa complex functions as a receptor mainly for fibrinogen and vitronectin but also for fibronectin and von Willebrand factor. Activation of this receptor complex is the "final common pathway" for platelet aggregation, and is important in platelet aggregation, the cross-linking of platelets by fibrin.

Platelet inhibition can be demonstrated two hours after a single dose of oral clopidogrel, but the onset of action is slow, so that a loading-dose of 300-600 mg is usually administered.

Mechanism of Action

Clopidogrel is an inhibitor of platelet aggregation. A variety of drugs that inhibit platelet function have been shown to decrease morbid events in people with established cardiovascular atherosclerotic disease as evidenced by stroke or transient ischemic attacks, myocardial infarction, unstable angina or the need for vascular bypass or angioplasty. This indicates that platelets participate in the initiation and/or evolution of these events and that inhibiting them can reduce the event rate.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION
PHARMALOGY >>
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Clopidogrel Bisulfate

Api Manufacturing At Taj

Acamprosate Calcium

Clomipramine Hcl

Alendronate Sodium

Clonazepam

Amitriptyline

Clopidogrel Bisulfate

Anastrozole

Danazol

Atomoxetine Hcl

Desloratadine

Balsalazide

Desmopressin Monoacetate

Bicalutamide

Divalproex Sodium

Budesonide

Dobutamine Hcl

Bupropion Hcl

Donepezil

Calcitonin

Dothiepin Hcl

Capecitabine

Entacapone

Carbamazepine

Eptifibatide

Carboplatin

Escitalopram HBr

Carisoprodol

Eszopiclone

Carvedilol

Finasteride

Cefuroxime Axetil

Flurbiprofen

Cisplatin

Fluticasone Propionate

Citalopram Hbr

Fluvoxamine Maleate

Fosphenytoin Sodium

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.